Bone Transplantation
Mostrando 25-36 de 632 artigos, teses e dissertações.
-
25. Medium modification with bone morphogenetic protein 2 addition for odontogenic differentiation
Abstract The aim of this study was to evaluate whether medium modification improves the odontogenic differentiation of human dental pulp stem cells (DPSC) in vitro and in vivo. DPSC isolated from human impacted third molar teeth were analysed for clusters of differentiation with flow cytometry. Odontogenic differentiation was stimulated by medium modificatio
Braz. oral res.. Publicado em: 08/03/2016
-
26. Clinical and histological study of permanent alopecia after bone marrow transplantation
Abstract: BACKGROUND: Permanent alopecia after bone marrow transplantation is rare, but more and more cases have been described, typically involving high doses of chemotherapeutic agents used in the conditioning regimen for the transplant. Busulfan, classically described in cases of irreversible alopecia, remains associated in recent cases. The pathogenesis
An. Bras. Dermatol.. Publicado em: 2015-12
-
27. Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemia
ABSTRACT Minimal residual disease is the most powerful predictor of outcome in acute leukemia and is useful in therapeutic stratification for acute lymphoblastic leukemia protocols. Nowadays, the most reliable methods for studying minimal residual disease in acute lymphoblastic leukemia are multiparametric flow cytometry and polymerase chain reaction. Both
Rev. Bras. Hematol. Hemoter.. Publicado em: 2015-12
-
28. Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience
OBJECTIVE: Hematopoietic stem cell transplantation has been successfully used to treat the pediatric population with malignant and non-malignant hematological diseases. This paper reports the results up to 180 days after the procedure of all unrelated hematopoietic stem cell transplantations in pediatric patients that were performed in one institution.METHOD
Rev. Bras. Hematol. Hemoter.. Publicado em: 2015-08
-
29. Immunohistochemical evaluation of CD20 expression in patients with multiple myeloma
Objective: CD20 expression was reported at different rates in patients with multiple myeloma. The importance of this B-cell antigen for plasma cells is still unknown. This study aimed to investigate CD20 expression of myeloma cells in bone marrow, and any relationship between the stage of disease, isotype and clinical features. Methods: Sixty-one patients w
Rev. Bras. Hematol. Hemoter.. Publicado em: 2015-02
-
30. Hemophagocytic lymphohistiocytosis: a case series of a Brazilian institution
Objective:To describe the clinical and laboratory presentation of hemophagocytic lymphohistiocytosis in children treated at a referral institution.Methods:A retrospective descriptive study was carried out of seven children diagnosed with hemophagocytic lymphohistiocytosis between 2010 and 2012. The criteria for diagnosis were those proposed by the Histiocyte
Rev. Bras. Hematol. Hemoter.. Publicado em: 2014-12
-
31. Nutritional status of patients submitted to transplantation of allogeneic hematopoietic stem cells: a retrospective study
Objective:This study aimed to describe and compare the nutritional status of adult patients submitted to allogeneic hematopoietic stem cell transplantation at two different time points (admission and discharge).Methods:A retrospective, descriptive and quantitative study was performed based on clinical, laboratory and nutritional data obtained from medical re
Rev. Bras. Hematol. Hemoter.. Publicado em: 2014-12
-
32. Quantification of mixed chimerism allows early therapeutic interventions
Hematopoietic stem cell transplantation is the curative option for patients with myelodysplastic syndrome; however, it requires a long post-transplantation follow-up. A 53-year-old woman with a diagnosis of myelodysplastic syndrome underwent related donor allogeneic hematopoietic stem cell transplantation in July 2006. Three months after transplantation, a c
Rev. Bras. Hematol. Hemoter.. Publicado em: 2014-10
-
33. Influence of cyclosporine on the occurrence of nephrotoxicity after allogeneic hematopoietic stem cell transplantation: a systematic review
Cyclosporine, a drug used in immunosuppression protocols for hematopoietic stem cell transplantation that has a narrow therapeutic index, may cause various adverse reactions, including nephrotoxicity. This has a direct clinical impact on the patient. This study aims to summarize available evidence in the scientific literature on the use of cyclosporine in re
Rev. Bras. Hematol. Hemoter.. Publicado em: 2014-10
-
34. Bone marrow mesenchymal stem cells overexpressing human basic fibroblast growth factor increase vasculogenesis in ischemic rats
Administration or expression of growth factors, as well as implantation of autologous bone marrow cells, promote in vivo angiogenesis. This study investigated the angiogenic potential of combining both approaches through the allogenic transplantation of bone marrow-derived mesenchymal stem cells (MSCs) expressing human basic fibroblast growth factor (hbFGF).
Braz J Med Biol Res. Publicado em: 08/08/2014
-
35. T-cell/myeloid mixed-phenotype acute leukemia with monocytic differentiation and isolated 17p deletion
Mixed phenotype acute leukemia is a rare subtype of leukemia that probably arises from a hematopoietic pluripotent stem cell. The co-expression of two of myeloid, B- or T-lymphoid antigens is the hallmark of this disease. Herein, the case of a 28-year-old female patient is reported who presented with hemoglobin of 5.8 g/dL, white blood cell count of 138 × 1
Rev. Bras. Hematol. Hemoter.. Publicado em: 2014-07
-
36. Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin America
This review aims to provide clinicians in Latin America with the most current information on the clinical aspects, diagnosis, and management of Hunter syndrome, a serious and progressive disease for which specific treatment is available. Hunter syndrome is a genetic disorder where iduronate-2-sulfatase (I2S), an enzyme that degrades glycosaminoglycans, is ab
Genet. Mol. Biol.. Publicado em: 2014-06